Predictors of short-term successful discontinuation of continuous renal replacement therapy: results from a prospective multicentre study

Table 7 Multivariate sensitivity analysis including only the patients with available urinary NGAL (63 patients)

	OR	95% CI	P-value
Creatinine clearance, ml/min (day 2)	1.088	1.028–1.151	0.004
Non-renal SOFA (day 2)	0.764	0.604–0.965	0.024

Variables included: Urine output (day 2), creatinine clearance, ml/min (day 2), Urinary NGAL (day 2) (ng/ml)/creatinine (mmol/L), vasopressor use (day 2), non-renal SOFA score (day 2), cumulative fluid balance day 0–2, duration of CRRT (days)
Variables removed: step 2: Urine output (day 2) was lost, step 3: Urinary NGAL (ng/ml)/creatinine (mmol/L) (day 2) was lost, step 4: Vasopressor use (day 2) was lost, step 5: duration of CRRT was lost, Step 6: cumulative fluid balance day 0–2 was lost
Nagelkerke R² of final model (n = 63) 0.406
OR Odds ratio; The odds ratios are per unit increase, SOFA sequential organ failure assessment

ISSN: 1471-2369